Transaction DateRecipientSharesTypePriceValue
15th October 2020Thomas Gad4,000Open or private sale$39.15$156,603.60
1st October 2020Thomas Gad4,000Open or private sale$38.88$155,524.40
29th September 2020James Healy950,000Other acquisition or disposition$0.00
29th September 2020James Healy213,546Other acquisition or disposition$0.00
15th September 2020Thomas Gad4,000Open or private sale$40.81$163,224.80
14th September 2020Thomas Gad22,569Open or private sale$41.00$925,426.05
14th September 2020Thomas Gad22,569Exercise of derivative$2.00$45,138.00
11th September 2020Thomas Gad13,571Open or private sale$40.33$547,330.64
11th September 2020Thomas Gad13,571Exercise of derivative$2.00$27,142.00
10th September 2020Thomas Gad13,860Exercise of derivative$2.00$27,720.00
Y M Abs Therapeutics
Y M Abs Therapeutics logo

Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company. It develops novel antibody therapeutics for oncology targets. The company's services include discovery, protein engineering, clinical and regulatory.

Ticker: YMAB
Sector: Healthcare
Industry: Biotechnology
SEC Central Index Key (CIK): 1722964
Employees: 32
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags